Shenzhen Mingsight Relin Pharmaceuticals Co., Ltd.

This early-stage trial tests an oral drug called MS-553 in 45 people with diabetic macular edema, a condition where fluid builds up in the eye's center, blurring vision. Participants take the drug daily for 8 weeks to see if it is safe and can reduce swelling or improve eyesight.…